Company Long-Term Loans and Borrowings: Ligand Pharma (LGND)

Public company logo of Ligand Pharma (LGND)

A lean team of highly loyal top executives optimizes internal costs for Ligand Pharmaceuticals (LGND). The organization's long-term debt profile reflects the balance of these expenses, where the 1.21 level captures the current state. The business relies on a "royalty farm" model for the B2B sector, while legally secured patent royalties from hundreds of biotechnological developments guarantee profit stability.

LGND Ligand Pharmaceuticals Company Long-Term Debts (07/04/2022 - 11/01/2026)

Summary analytical data breakdowns for Ligand Pharma (LGND)

- market price and analyst price targets:
Stock Price ligand.com|LGND - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Ligand|LGND - Total Company Value
- book capitalization information:
Accounting Value per Share Ligand|LGND - Book Capitalization|Market Capitalization to Book Value Ratio ligand.com|LGND - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Ligand Pharmaceuticals|LGND - Long-Term Debt to Equity|Current Liabilities to Capital Ligand Corp|LGND - Company Total Debt|Debt to Book Capital Ligand|LGND - Company Long-Term Debts|Company Short-Term Loans and Borrowings Ligand|Immediate Liquidity ligand.com
- earnings and multiples data:
LGND - Company Net Income
Fundamental company valuation:ligand.com LGND
Brand item of Ligand

The royalty-focused licensing model of Ligand Pharmaceuticals (LGND) minimizes R&D expenditures, rendering the borrowing structure a critical indicator of financial autonomy. By analyzing the dynamics of the business's long-term debt, investors assess total liabilities with maturities exceeding one year to determine the company's ability to service debt without compromising patent development or the stability of share prices during periods of market volatility.

Who Ligand Pharmaceuticals competes with

Company Long-Term Debts haleon.com HLN|KVUE - Company Long-Term Debt|Company Long-Term Loans and Borrowings VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Company Long-Term Debt|Company Long-Term Liabilities Amneal Corp|PRGO (Perrigo Company plc) - Company Long-Term Debts|Company Long-Term Debts alvotech.com|Company Long-Term Liabilities LQDA (Liquidia)|GLPG (Galapagos N.V.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt ANI Pharma ANIP|Afrezza (MNKD) - Long-Term Debt|AMPH: Company Long-Term Liabilities|pacira.com - Amount of Long-Term Liabilities|SPRY: Company Long-Term Debts|Theravance Biopharma Inc - Company Long-Term Loans and Borrowings|AQST (Aquestive Pharma) - Company Long-Term Debts|Long-Term Debt scPharma SCPH|Company Long-Term Debt Tectonic Therapeutic, Inc. (TECX)|TNXP (tonixpharma.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt China SXT Pharmaceuticals, Inc. SXTC|Eupraxia Pharmaceuticals, Inc. - Company Long-Term Debt|BioHarvest - Company Long-Term Debts|Long-Term Debt Volume Invizyne EXOZ|ORMP: Company Long-Term Debts|Long-Term Indebtedness Entera Bio ENTX|HYFT (MindWalk Holdings Inc.) - Company Long-Term Debts|Company Long-Term Debts ABVC BioPharma Inc.|Company Long-Term Debt Cumberland Pharma (CPIX)|Quantum BioPharma Corp - Company Long-Term Indebtedness|Company Long-Term Debts FGEN (FibroGen, Inc.)|TELO: Company Long-Term Indebtedness|RANI: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings SNYR (Synergy CHC Corp)|rallybio.com (RLYB) - Company Long-Term Debt|Long-Term Liabilities LEXX (Lexaria Bioscience Corp.)|PULM (Pulmatrix, Inc.) - Company Long-Term Debts|PTHL: Company Long-Term Loans and Borrowings|Company Long-Term Debts APM|Company Long-Term Debts Lyra Therapeutics Inc. (LYRA)|Company Long-Term Debt Impact BioMedical Inc IBO|Company Long-Term Loans and Borrowings TNFA|YCBD - Company Long-Term Debt|painreform.com (PRFX) - Company Long-Term Liabilities|CYTO: Company Long-Term Debts|Lipella Pharmaceuticals Inc (LIPO) - Company Long-Term Debts|OPTN (Optinose) - Company Long-Term Debts|Company Long-Term Liabilities Pieris Pharma (PIRS)|Company Long-Term Debts PROC|PTPI - Long-Term Debt|Qilian International Holding - Company Long-Term Liabilities|Company Long-Term Debts Acelyrin Inc. SLRN|TFFP: Company Long-Term Liabilities